Erudio Healtherudio.com
Drug
Lurbinectedin trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying lurbinectedin: IDeate-Lung02. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 11 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| IDeate-Lung02 NCT06203210 · Daiichi Sankyo | relapsed small cell lung cancer | Phase 3 | 161 | 33 | Standard | Nov 5, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| IMforte NCT05091567 · Hoffmann-La Roche DeepView → | extensive-stage small-cell lung cancer | Phase 3 | Deep | View | |||
| DeLLphi-304 NCT05740566 · Amgen DeepView → | relapsed small cell lung cancer | Phase 3 | Deep | View | |||
| LUPER NCT04358237 · Antonio Calles Blanco DeepView → | relapsed small cell lung cancer | Phase 1/Phase 2 | Deep | View | |||
| SEZanne NCT07155174 · AbbVie FocusedView → | previously untreated extensive-stage small cell lung cancer | Phase 2 | Focused | View | |||
| PM1183-B-005-14 NCT02454972 · PharmaMar FocusedView → | advanced solid tumors | Phase 2 | Focused | View | |||
| SKYBRIDGE NCT05652686 · Phanes Therapeutics FocusedView → | DLL3-expressing neuroendocrine carcinomas | Phase 1/Phase 2 | Focused | View | |||
| ATLANTIS NCT02566993 · PharmaMar FocusedView → | Not given | Phase 3 | Focused | View | |||
| LiDer NCT06385548 · Vall d'Hebron Institute of Oncology FocusedView → | advanced/recurrent endometrial cancer following platinum chemotherapy | Phase 1/Phase 2 | Focused | View | |||
| NCT07365241 NCT07365241 · AbbVie FocusedView → | relapsed/refractory small cell lung cancer | Phase 3 | Focused | View | |||
| LAGOON NCT05153239 · PharmaMar FocusedView → | Not given | Phase 3 | Focused | View | |||
| EVOKE-SCLC-04 NCT06801834 · Gilead Sciences FocusedView → | previously treated extensive stage small cell lung cancer | Phase 3 | Focused | View | |||